Spectral Medical's Stock Target Lowers to $0.35

Market by 2FIRSTS.ai
Oct.25.2023
Spectral Medical's Stock Target Lowers to $0.35
Spectral Medical's stock target lowered to $0.35 by Stifel Nicolaus, impacting the company's position in the tobacco industry.

According to BayStreet's report on October 24th, the stock price target of Spectral Medical, a manufacturer of smokeless products, has been downgraded from 0.40 CAD to 0.35 CAD by stock analyst Stifel Nicolaus in a research report.

 

According to reports, Standard Diversified Inc is a holding company that owns and operates subsidiary companies in various industries, including other tobacco products, insurance, and outdoor advertising. They engage in the production and marketing of both smokeless and smoking tobacco products, as well as next-generation tobacco products. Their divisions manufacture and market moist snuff, and also serve as contract manufacturers and marketers of chewing tobacco products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Related Topics